Pulsus Group, headquartered in Hyderabad, has announced the creation of an artificial intelligence (AI)-based pharma healthcare IT hub in Ameenpur, Sangareddy, Telangana, at an estimated cost of Rs 300 crore. This project, announced by Dr Srinubabu Gedela, CEO and MD, Pulsus Group, at the 73rd Indian Pharmaceutical Congress in Hyderabad, is set to revolutionise the healthcare and IT landscape while generating a significant economic impact by creating approximately 50,000 jobs.
Early projections indicate the hub will create 10,000 direct positions within the facility itself and an estimated 40,000 indirect jobs through supporting industries and services.

"This AI-powered hub will be aligned with the Congress theme 'Role of Indian Pharma: For Global Wellbeing’. By integrating the most advanced artificial intelligence, we aim to streamline processes, enhance precision in drug development, and improve patient outcomes. This positions Telangana at the forefront of healthcare innovation in India,” said Srinubabu Gedela.

Key features of the project include innovative AI applications across all aspects of pharma, from research and development to healthcare delivery. The hub will generate substantial employment opportunities for local residents, enriching the region's economy.

Located within the designated IT/ITeS Zone in Ameenpur, the hub, benefits from exceptional infrastructure and connectivity. The project has received dedicated support from the Telangana government and the Software Technology Parks of India, highlighting its strategic importance.